title: EphB2 SNPs and sporadic prostate cancer risk in African American men.
abstract: The EphB2 gene has been implicated as a tumor suppressor gene somatically altered in both prostate cancer (PC) and colorectal cancer. We have previously shown an association between an EphB2 germline nonsense variant and risk of familial prostate cancer among African American Men (AAM). Here we set out to test the hypothesis that common variation within the EphB2 locus is associated with increased risk of sporadic PC in AAM. We genotyped a set of 341 single nucleotide polymorphisms (SNPs) encompassing the EphB2 locus, including known and novel coding and noncoding variants, in 490 AA sporadic PC cases and 567 matched controls. Single marker-based logistical regression analyses revealed seven EphB2 SNPs showing statistically significant association with prostate cancer risk in our population. The most significant association was achieved for a novel synonymous coding SNP, TGen-624, (Odds Ratio (OR)  = 0.22; 95% Confidence Interval (CI) 0.08-0.66, p = 1×10(-5)). Two other SNPs also show significant associations toward a protective effect rs10465543 and rs12090415 (p = 1×10(-4)), OR = 0.49 and 0.7, respectively. Two additional SNPs revealed trends towards an increase in risk of prostate cancer, rs4612601 and rs4263970 (p = 0.001), OR = 1.35 and 1.31, respectively. Furthermore, haplotype analysis revealed low levels of linkage disequilibrium within the region, with two blocks being associated with prostate cancer risk among our population. These data suggest that genetic variation at the EphB2 locus may increase risk of sporadic PC among AAM.
authors: Division of Integrated Cancer Genomics, Translational Genomics Research Institute, Phoenix, Arizona, United States of America.
authors: Christiane M
authors: CM
authors: Robbins
authors: Stanley
authors: S
authors: Hooker
authors: Rick A
authors: RA
authors: Kittles
authors: John D
authors: JD
authors: Carpten
references: Genome Res. 2007 Dec;17(12):1717-22
references: 17978284
references: Cancer Res. 2005 Nov 15;65(22):10170-3
references: 16288001
references: Prostate. 1990;17(4):337-47
references: 2251225
references: Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57
references: 15824169
references: Carcinogenesis. 2009 Aug;30(8):1353-7
references: 19520795
references: Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2145-9
references: 19549807
references: BMC Cancer. 2010 Jun 28;10:334
references: 20584312
references: J Med Genet. 2006 Jun;43(6):507-11
references: 16155194
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: Bioinformatics. 2005 Jan 15;21(2):263-5
references: 15297300
references: Nature. 2007 Oct 18;449(7164):851-61
references: 17943122
references: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14068-73
references: 16945910
references: Bull Soc Sci Med Grand Duche Luxemb. 2006;(1):21-8
references: 16869093
references: Nat Genet. 2004 Sep;36(9):979-83
references: 15300251
references: J Urol. 2010 May;183(5):1792-6
references: 20299055
references: Cancer Lett. 2001 Mar 10;164(1):97-104
references: 11166921
references: Rev Urol. 2002;4 Suppl 5:S3-S10
references: 16986064
references: Hum Genet. 2009 Nov;126(5):637-42
references: 19568772
references: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):588-99
references: 20086112
references: Prostate Cancer Prostatic Dis. 2010 Sep;13(3):270-7
references: 20231859
references: Am J Hum Genet. 2007 Sep;81(3):559-75
references: 17701901
references: Nat Genet. 2006 Jun;38(6):652-8
references: 16682969
references: Genetics. 2003 Aug;164(4):1567-87
references: 12930761